Sangamo Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Conference

August 10, 2020 at 8:30 AM EDT

BRISBANE, Calif.--(BUSINESS WIRE)--Aug. 10, 2020-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Sandy Macrae, CEO of Sangamo, will present at the 2020 Wedbush PacGrow Healthcare Conference on August 12, 2020 at 2:55 p.m. Eastern Time.

The presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations.

About Sangamo Therapeutics 

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit

Investor Relations – Global
McDavid Stilwell
510-970-6000, x219

Media Inquiries – Global
Aron Feingold
510-970-6000, x421

Source: Sangamo Therapeutics, Inc.